Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1481-1487
Published online before print July 16, 2009, doi: 10.1161/ATVBAHA.109.191940
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/10/1481    most recent
ATVBAHA.109.191940v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kennedy, D. J.
Right arrow Articles by Febbraio, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kennedy, D. J.
Right arrow Articles by Febbraio, M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1481.)
© 2009 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Dietary Cholesterol Plays a Role in CD36-Mediated Atherogenesis in LDLR-Knockout Mice

David J. Kennedy; Sai D. Kuchibhotla; Ella Guy; Young Mi Park; George Nimako; DiFernando Vanegas; Richard E. Morton; Maria Febbraio

From the Department of Cell Biology (D.J.K., S.D.K., Y.M.P., G.N., D.V., R.E.M., M.F.), Cleveland Clinic, Ohio; and the Department of Medicine (E.G.), Weill Medical College of Cornell University, New York.

Correspondence to Maria Febbraio, PhD, Department of Cell Biology, NC-10, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland OH 44195. E-mail febbram{at}ccf.org

Objective— CD36 has been shown to play a role in atherosclerosis in the apolipoprotein E-knockout (apoEo) mouse. We observed no difference in aortic lesion area between Western diet (WD)-fed LDLRo and LDLRo/CD36o mice. The objective was to understand the mechanism of CD36-dependent atherogenesis.

Methods and Results— ApoEo mice transplanted with bone marrow from LDLRo/CD36o mice had significantly less aortic lesion compared with those transplanted with LDLRo marrow. Reciprocal macrophage transfer into hyperlipidemic apoEo and LDLRo animals showed that foam cell formation induced by in vivo modified lipoproteins was dependent on the lipoprotein, not macrophage type. LDLRo and LDLRo/CD36o mice were fed a cholesterol-enriched diet (HC), and we observed significant lesion inhibition in LDLRo/CD36o mice. LDL/plasma isolated from HC-fed LDLRo mice induced significantly greater jnk phosphorylation, cytokine release, and reactive oxygen species secretion than LDL/plasma from WD-fed LDLRo mice, and this was CD36-dependent. HC-fed LDLRo mice had higher circulating levels of cytokines than WD-fed mice.

Conclusions— These data support the hypothesis that CD36-dependent atherogenesis is contingent on a proinflammatory milieu that promotes the creation of specific CD36 ligands, not solely hypercholesterolemia, and may explain the greater degree/accelerated rate of atherosclerosis observed in syndromes associated with inflammatory risk.

In the LDLR knockout mouse model of atherogenesis, dietary cholesterol played a role in CD36-dependent lesion burden. Addition of cholesterol resulted in increased inflammation and release of reactive oxygen species by macrophages, which was abrogated in the absence of CD36. A proinflammatory milieu may be essential to creation of CD36-specific proatherogenic ligands.


Key Words: CD36 • atherosclerosis • murine models • inflammation • scavenger receptor